PDF(Pubmed)
Abstract：
BACKGROUND: Amidst the escalating prevalence of glucose-related chronic diseases, the advancements, potential uses, and growing accessibility of continuous glucose monitors (CGM) have piqued the interest of healthcare providers, consumers, and health behaviour researchers. Yet, there is a paucity of literature characterising the use of CGM in behavioural intervention research. This scoping review aims to describe targeted populations, health behaviours, health-related outcomes, and CGM protocols in randomised controlled trials (RCTs) that employed CGM to support health behaviour change.
METHODS: We searched Ovid MEDLINE, Elsevier Embase, Cochrane Central Register of Controlled Trials, EBSCOhost PsycINFO, and ProQuest Dissertations & Theses Global from inception to January 2024 for RCTs of behavioural interventions conducted in adults that incorporated CGM-based biological feedback. Citation searching was also performed. The review protocol was registered ( https://doi.org/10.17605/OSF.IO/SJREA ).
RESULTS: Collectively, 5389 citations were obtained from databases and citation searching, 3995 articles were screened, and 31 were deemed eligible and included in the review. Most studies (n = 20/31, 65%) included adults with type 2 diabetes and reported HbA1c as an outcome (n = 29/31, 94%). CGM was most commonly used in interventions to target changes in diet (n = 27/31, 87%) and/or physical activity (n = 16/31, 52%). 42% (n = 13/31) of studies provided prospective CGM-based guidance on diet or activity, while 61% (n = 19/31) included retrospective CGM-based guidance. CGM data was typically unblinded (n = 24/31, 77%) and CGM-based biological feedback was most often provided through the CGM and two-way communication (n = 12/31, 39%). Communication typically occurred in-person (n = 13/31, 42%) once per CGM wear (n = 13/31; 42%).
CONCLUSIONS: This scoping review reveals a predominant focus on diabetes in CGM-based interventions, pointing out a research gap in its wider application for behaviour change. Future research should expand the evidence base to support the use of CGM as a behaviour change tool and establish best practices for its implementation.
BACKGROUND: doi.org/10.17605/OSF.IO/SJREA.
METHODS: We searched Ovid MEDLINE, Elsevier Embase, Cochrane Central Register of Controlled Trials, EBSCOhost PsycINFO, and ProQuest Dissertations & Theses Global from inception to January 2024 for RCTs of behavioural interventions conducted in adults that incorporated CGM-based biological feedback. Citation searching was also performed. The review protocol was registered ( https://doi.org/10.17605/OSF.IO/SJREA ).
RESULTS: Collectively, 5389 citations were obtained from databases and citation searching, 3995 articles were screened, and 31 were deemed eligible and included in the review. Most studies (n = 20/31, 65%) included adults with type 2 diabetes and reported HbA1c as an outcome (n = 29/31, 94%). CGM was most commonly used in interventions to target changes in diet (n = 27/31, 87%) and/or physical activity (n = 16/31, 52%). 42% (n = 13/31) of studies provided prospective CGM-based guidance on diet or activity, while 61% (n = 19/31) included retrospective CGM-based guidance. CGM data was typically unblinded (n = 24/31, 77%) and CGM-based biological feedback was most often provided through the CGM and two-way communication (n = 12/31, 39%). Communication typically occurred in-person (n = 13/31, 42%) once per CGM wear (n = 13/31; 42%).
CONCLUSIONS: This scoping review reveals a predominant focus on diabetes in CGM-based interventions, pointing out a research gap in its wider application for behaviour change. Future research should expand the evidence base to support the use of CGM as a behaviour change tool and establish best practices for its implementation.
BACKGROUND: doi.org/10.17605/OSF.IO/SJREA.
摘要：
背景：在与葡萄糖相关的慢性病患病率不断上升的情况下，进步,潜在用途,连续葡萄糖监测仪（CGM）的可及性不断增加，引起了医疗保健提供者的兴趣，消费者,和健康行为研究人员。然而，在行为干预研究中使用CGM的文献很少。本范围审查旨在描述目标人群，健康行为,与健康相关的结果，和使用CGM支持健康行为改变的随机对照试验(RCT)中的CGM方案。
方法：我们搜索了OvidMEDLINE，ElsevierEmbase,Cochrane中央控制试验登记册,EBSCOhostPsycINFO,和ProQuest论文和论文全球从开始到2024年1月，用于在成年人中进行的行为干预的RCT，其中包含基于CGM的生物反馈。还进行了引文搜索。审查协议已注册（https://doi.org/10.17605/OSF。IO/SJREA）。
结果：总的来说，从数据库和引文搜索中获得5389篇引文，筛选了3995篇文章，31人被认为符合资格，并被纳入审查。大多数研究（n=20/31，65％）包括患有2型糖尿病的成年人，并报告HbA1c作为结果（n=29/31，94％）。CGM最常用于针对饮食变化（n=27/31，87％）和/或身体活动（n=16/31，52％）的干预措施。42％（n=13/31）的研究提供了基于CGM的前瞻性饮食或活动指导，61%(n=19/31)包括基于CGM的回顾性指导。CGM数据通常是非盲的（n=24/31，77％），并且基于CGM的生物反馈最常通过CGM和双向通信提供（n=12/31，39％）。每次CGM磨损（n=13/31；42％）通常发生一次交流（n=13/31，42％）。
结论：这项范围审查揭示了在基于CGM的干预措施中，糖尿病的主要关注点，指出其在行为改变方面的广泛应用存在研究空白。未来的研究应扩大证据基础，以支持将CGM用作行为改变工具，并为其实施建立最佳实践。
背景：doi.org/10.17605/OSF。IO/SJREA。
方法：我们搜索了OvidMEDLINE，ElsevierEmbase,Cochrane中央控制试验登记册,EBSCOhostPsycINFO,和ProQuest论文和论文全球从开始到2024年1月，用于在成年人中进行的行为干预的RCT，其中包含基于CGM的生物反馈。还进行了引文搜索。审查协议已注册（https://doi.org/10.17605/OSF。IO/SJREA）。
结果：总的来说，从数据库和引文搜索中获得5389篇引文，筛选了3995篇文章，31人被认为符合资格，并被纳入审查。大多数研究（n=20/31，65％）包括患有2型糖尿病的成年人，并报告HbA1c作为结果（n=29/31，94％）。CGM最常用于针对饮食变化（n=27/31，87％）和/或身体活动（n=16/31，52％）的干预措施。42％（n=13/31）的研究提供了基于CGM的前瞻性饮食或活动指导，61%(n=19/31)包括基于CGM的回顾性指导。CGM数据通常是非盲的（n=24/31，77％），并且基于CGM的生物反馈最常通过CGM和双向通信提供（n=12/31，39％）。每次CGM磨损（n=13/31；42％）通常发生一次交流（n=13/31，42％）。
结论：这项范围审查揭示了在基于CGM的干预措施中，糖尿病的主要关注点，指出其在行为改变方面的广泛应用存在研究空白。未来的研究应扩大证据基础，以支持将CGM用作行为改变工具，并为其实施建立最佳实践。
背景：doi.org/10.17605/OSF。IO/SJREA。
